UK Viral Vector And Plasmid Dna Manufacturing Market Size & Outlook
UK viral vector and plasmid dna manufacturing market, 2018-2030 (US$M)
Related Markets
UK viral vector and plasmid dna manufacturing market highlights
- The UK viral vector and plasmid dna manufacturing market generated a revenue of USD 221.1 million in 2023 and is expected to reach USD 951.0 million by 2030.
- The UK market is expected to grow at a CAGR of 23.2% from 2024 to 2030.
- In terms of segment, adeno-associated virus (aav) was the largest revenue generating vector type in 2023.
- Adeno-associated virus (AAV) is the most lucrative vector type segment registering the fastest growth during the forecast period.
Viral vector and plasmid dna manufacturing market data book summary
| Market revenue in 2023 | USD 221.1 million |
| Market revenue in 2030 | USD 951.0 million |
| Growth rate | 23.2% (CAGR from 2023 to 2030) |
| Largest segment | Adeno-associated virus (aav) |
| Fastest growing segment | Adeno-associated virus (AAV) |
| Historical data | 2018 - 2022 |
| Base year | 2023 |
| Forecast period | 2024 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Adeno-associated virus (AAV), Lentivirus, Adenovirus, Retrovirus, Plasmids |
| Key market players worldwide | Merck KGaA, Lonza Group Ltd, FUJIFILM Holdings Corp, Thermo Fisher Scientific Inc, Catalent Inc, WuXi Biologics (Cayman) Inc, Takara Bio Inc, Batavia Biosciences, Miltenyi Biotec, Revvity Inc, BioNTech SE ADR, Astellas Pharma Inc, Biomarin Pharmaceutical Inc, Regenxbio Inc |
Other key industry trends
- In terms of revenue, UK accounted for 4.1% of the global viral vector and plasmid dna manufacturing market in 2023.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
- In Europe, Germany viral vector and plasmid dna manufacturing market is projected to lead the regional market in terms of revenue in 2030.
- UK is the fastest growing regional market in Europe and is projected to reach USD 951.0 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Viral Vector And Plasmid DNA Manufacturing Market Scope
Viral Vector And Plasmid DNA Manufacturing Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
UK viral vector and plasmid dna manufacturing market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to viral vector and plasmid dna manufacturing market will help companies and investors design strategic landscapes.
Adeno-associated virus (aav) was the largest segment with a revenue share of 19.99% in 2023. Horizon Databook has segmented the UK viral vector and plasmid dna manufacturing market based on adeno-associated virus (aav), lentivirus, adenovirus, retrovirus, plasmids covering the revenue growth of each sub-segment from 2018 to 2030.
According to a 2019 survey conducted by the Cell and Gene Therapy Catapult, UK, there were 26 MIA and MHRA MIA (IMP) licensed gene & cell therapy manufacturing facilities in the UK.
Moreover, there were two licensed commercial production (MIA) facilities in the country, as of November 2019.
This well-established facility network coupled with a strong workforce is anticipated to fuel market growth. In recent years, the country witnessed significant growth in the commercial sector.
Reasons to subscribe to UK viral vector and plasmid dna manufacturing market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of UK viral vector and plasmid dna manufacturing market databook
-
Our clientele includes a mix of viral vector and plasmid dna manufacturing market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the UK viral vector and plasmid dna manufacturing market , including forecasts for subscribers. This country databook contains high-level insights into UK viral vector and plasmid dna manufacturing market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
UK viral vector and plasmid dna manufacturing market size, by vector type, 2018-2030 (US$M)
UK Viral Vector And Plasmid DNA Manufacturing Market Outlook Share, 2023 & 2030 (US$M)
Related regional statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
